AGL36.58▼ -1.42 (-0.04%)AIRLINK215.74▲ 1.83 (0.01%)BOP9.48▲ 0.06 (0.01%)CNERGY6.52▲ 0.23 (0.04%)DCL8.61▼ -0.16 (-0.02%)DFML41.04▼ -1.17 (-0.03%)DGKC98.98▲ 4.86 (0.05%)FCCL36.34▲ 1.15 (0.03%)FFL17.08▲ 0.69 (0.04%)HUBC126.34▼ -0.56 (0.00%)HUMNL13.44▲ 0.07 (0.01%)KEL5.23▼ -0.08 (-0.02%)KOSM6.83▼ -0.11 (-0.02%)MLCF44.1▲ 1.12 (0.03%)NBP59.69▲ 0.84 (0.01%)OGDC221.1▲ 1.68 (0.01%)PAEL40.53▲ 1.37 (0.03%)PIBTL8.08▼ -0.1 (-0.01%)PPL191.53▼ -0.13 (0.00%)PRL38.55▲ 0.63 (0.02%)PTC27▲ 0.66 (0.03%)SEARL104.33▲ 0.33 (0.00%)TELE8.63▲ 0.24 (0.03%)TOMCL34.96▲ 0.21 (0.01%)TPLP13.7▲ 0.82 (0.06%)TREET24.89▼ -0.45 (-0.02%)TRG73.55▲ 3.1 (0.04%)UNITY33.27▼ -0.12 (0.00%)WTL1.71▼ -0.01 (-0.01%)

COMSTECH organizing training in medicines for OIC states

Share
Tweet
WhatsApp
Share on Linkedin
[tta_listen_btn]
Staff Reporter

COMSTECH is organizing a day long training to promote “Collaboration among OIC member countries for Promotion of Research Culture in Medicine and Vaccine Development through Strengthening and Upgrading the Clinical Trials” on June 03. The training will be held at COMSTECH Secretariat, Islamabad.

This is a hybrid event with limited in-person participation of local experts and large scale virtual participation from OIC member states i.e. Iran, Azerbaijan, Bangladesh, Nigeria, Cameroon, Egypt, Saudi Arabia, Iraq, Pakistan and Jordan.

The objective of this training is to provide a valuable platform to deliberate upon and develop a joint mechanism for research and development, specifically clinical trials, as a step towards self-reliance of OIC member states in medicine and vaccine development.

This training is being organized in continuation of COMSTECH efforts to bolster self-reliance of in OIC member states medicine and vaccine development as adopted in Jakarta Declaration and OIC Action Plan 2019-2021.

Speakers of training will illuminate the mechanism of conducting clinical trials by the member countries besides developing a framework for capacity building, knowledge sharing and technology transfer mechanism.

This training will provide an opportunity where technically advanced OIC member states would upgrade the capacity of the other member countries focusing on the conduction of multi-center and multi-country clinical trials.

This event is being held in close association with the Drug Regulatory Authority of Pakistan (DRAP) and International Centre of Chemical and Biological Sciences (ICCBS).

Related Posts

Get Alerts

© 2024 All rights reserved | Pakistan Observer